MedTrace Logo

PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm

NCT05195905 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-04-16

No results posted yet for this study

Summary

The primary objective is to evaluate the safety and effectiveness of surgeon modified endografts for the treatment of pararenal and thoracoabdominal aortic pathology in patients who are not candidate for traditional open repair due to comorbid issues and their anatomy is not amenable to commercially available endografts.

Conditions

  • Pararenal Aortic Aneurysm
  • Thoracoabdominal Aortic Aneurysm

Interventions

DEVICE

PMEG

All devices that will be modified in this study protocol are commercially available in the United States. The commercially available endografts will be used to construct a fenestrated/branched device for this intervention.

Sponsors & Collaborators

  • Konstantinos Dean Arnaoutakis, MD

    lead OTHER

Principal Investigators

  • Konstantinos Arnaoutakis, MD · University of South Florida

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-06
Primary Completion
2029-02-28
Completion
2029-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05195905 on ClinicalTrials.gov